Contents

Search

velaglucerase alfa (Vpriv)

Indications: - treatment of Gaucher's disease type-1

General

recombinant protein; chimer metabolic agent (metabolic modifier) glucosylceramidase; lysosomal acid glucosylceramidase; acidic beta glucosidase; beta-glucocerebrosidase (GBA1, GBA, GC, GLUC)

References

  1. Aerts J et al Velaglucerase alfa Nature Reviews Drug Discovery 9, 837-838 (November 2010) http://www.nature.com/nrd/journal/v9/n11/full/nrd3311.html
  2. Wikipedia: Velaglucerase alfa http://en.wikipedia.org/wiki/Velaglucerase_alfa
  3. Drugs.com http://www.drugs.com/mtm/velaglucerase-alfa.html